|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.5 HKD | +0.77% |
|
-1.69% | -15.59% |
| May. 09 | Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director | CI |
| Mar. 22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
Zylox-Tonbridge Medical Technology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 152.74 million compared to CNY 71.48 million a year ago. Net loss was CNY 25.5 million compared to CNY 69.72 million a year ago.
Basic loss per share from continuing operations was CNY 0.08 compared to CNY 0.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.59% | 437M | |
| +10.39% | 126B | |
| +2.52% | 8.97B | |
| +38.96% | 5.56B | |
| -17.50% | 4.99B | |
| +8.36% | 3.44B | |
| -8.84% | 2.8B | |
| -7.52% | 2.18B | |
| -3.00% | 2.16B | |
| -21.88% | 1.82B |
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. 